Recently, it was found that NGAL released in urine is a noninvasive diagnostic marker for HCC detection and that patients with chronic liver disease would benefit from using urinary NGAL to diagnose HCC [47]. This evidence concerns the gene LCN2 and hepatocellular carcinoma.